Intercept Pharmaceuticals
ICPT
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)
Categories
Intercept Pharmaceuticals (ICPT) - Net assets
Net assets on the balance sheet as of September 2023 : $71.84 M
According to Intercept Pharmaceuticals
's latest financial reports the company has $71.84 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Intercept Pharmaceuticals - Net assets on balance sheet (from 2011 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $93.07 M | -150.6% |
| 2021-12-31 | $-0.19 B | 10.25% |
| 2020-12-31 | $-0.17 B | -423.63% |
| 2019-12-31 | $51.55 M | 169.5% |
| 2018-12-31 | $19.13 M | 16.75% |
| 2017-12-31 | $16.38 M | -94.8% |
| 2016-12-31 | $0.31 B | -47.7% |
| 2015-12-31 | $0.60 B | 160.79% |
| 2014-12-31 | $0.23 B | 180.19% |
| 2013-12-31 | $82.4 M | 25.02% |
| 2012-12-31 | $65.91 M | -2674.91% |
| 2011-12-31 | $-2.56 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $10.86 B | 15,021.02% | 🇺🇸 USA |
 Gilead Sciences GILD | $22.74 B | 31,564.00% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $29.48 B | 40,939.74% | 🇺🇸 USA |
 MediciNova MNOV | $62.37 M | -13.18% | 🇺🇸 USA |